Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers
- PMID: 20921021
- PMCID: PMC3003879
- DOI: 10.1136/jmg.2010.079814
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers
Abstract
Background: Germline mutations in CDH1 are associated with hereditary diffuse gastric cancer; lobular breast cancer also occurs excessively in families with such condition.
Method: To determine if CDH1 is a susceptibility gene for lobular breast cancer in women without a family history of diffuse gastric cancer, germline DNA was analysed for the presence of CDH1 mutations in 318 women with lobular breast cancer who were diagnosed before the age of 45 years or had a family history of breast cancer and were not known, or known not, to be carriers of germline mutations in BRCA1 or BRCA2. Cases were ascertained through breast cancer registries and high-risk cancer genetic clinics (Breast Cancer Family Registry, the kConFab and a consortium of breast cancer genetics clinics in the United States and Spain). Additionally, Multiplex Ligation-dependent Probe Amplification was performed for 134 cases to detect large deletions.
Results: No truncating mutations and no large deletions were detected. Six non-synonymous variants were found in seven families. Four (4/318 or 1.3%) are considered to be potentially pathogenic through in vitro and in silico analysis.
Conclusion: Potentially pathogenic germline CDH1 mutations in women with early-onset or familial lobular breast cancer are at most infrequent.
Conflict of interest statement
Similar articles
-
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11. Gastroenterology. 2015. PMID: 26072394
-
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.JAMA Netw Open. 2024 Apr 1;7(4):e247862. doi: 10.1001/jamanetworkopen.2024.7862. JAMA Netw Open. 2024. PMID: 38652475 Free PMC article.
-
Germline CDH1 mutations in bilateral lobular carcinoma in situ.Br J Cancer. 2014 Feb 18;110(4):1053-7. doi: 10.1038/bjc.2013.792. Epub 2013 Dec 24. Br J Cancer. 2014. PMID: 24366306 Free PMC article.
-
Hereditary diffuse gastric and lobular breast cancer syndrome associated with germline CDH1 variants: focus on lobular breast cancer.J Cancer Res Clin Oncol. 2025 May 14;151(5):164. doi: 10.1007/s00432-025-06222-w. J Cancer Res Clin Oncol. 2025. PMID: 40366456 Free PMC article. Review.
-
CDH1 germline mutations and hereditary lobular breast cancer.Fam Cancer. 2016 Apr;15(2):215-9. doi: 10.1007/s10689-016-9869-5. Fam Cancer. 2016. PMID: 26759166 Review.
Cited by
-
Next-generation sequencing for inherited breast cancer risk: counseling through the complexity.Curr Oncol Rep. 2014 Mar;16(3):371. doi: 10.1007/s11912-013-0371-z. Curr Oncol Rep. 2014. PMID: 24488544 Review.
-
Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.Fam Cancer. 2019 Apr;18(2):253-260. doi: 10.1007/s10689-018-0111-5. Fam Cancer. 2019. PMID: 30306390 Review.
-
Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?Fam Cancer. 2016 Jan;15(1):41-7. doi: 10.1007/s10689-015-9833-9. Fam Cancer. 2016. PMID: 26358115
-
Frequency of CDH1 Germline Mutations in Non-Gastric Cancers.Cancers (Basel). 2021 May 12;13(10):2321. doi: 10.3390/cancers13102321. Cancers (Basel). 2021. PMID: 34066044 Free PMC article. Review.
-
Lobular carcinoma in situ: diagnostic criteria and molecular correlates.Mod Pathol. 2021 Jan;34(Suppl 1):8-14. doi: 10.1038/s41379-020-00689-3. Epub 2020 Oct 6. Mod Pathol. 2021. PMID: 33024303 Review.
References
-
- Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402–5 - PubMed
-
- Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE, Seruca R, Caldas C. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 2002;19:510–17 - PubMed
-
- Pharoah PD, Guilford P, Caldas C. International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001;121:1348–53 - PubMed
-
- Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, Nikkel S, Connolly-Wilson M, Weissman S, Rubinstein WS, Sebold C, Greenstein R, Stroop J, Yim D, Panzini B, McKinnon W, Greenblatt M, Wirtzfeld D, Fontaine D, Coit D, Yoon S, Chung D, Lauwers G, Pizzuti A, Vaccaro C, Redal MA, Oliveira C, Tischkowitz M, Olschwang S, Gallinger S, Lynch H, Green J, Ford J, Pharoah P, Fernandez B, Huntsman D. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007;297:2360–72 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 CA069417/CA/NCI NIH HHS/United States
- U01 CA069638/CA/NCI NIH HHS/United States
- U01 CA69417/CA/NCI NIH HHS/United States
- P50 CA089393/CA/NCI NIH HHS/United States
- U01 CA069398/CA/NCI NIH HHS/United States
- U01 CA69638/CA/NCI NIH HHS/United States
- U01 CA69631/CA/NCI NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- UL1 RR 025758/RR/NCRR NIH HHS/United States
- U01 CA69467/CA/NCI NIH HHS/United States
- P50-CA89393/CA/NCI NIH HHS/United States
- U01 CA069467/CA/NCI NIH HHS/United States
- RFA-CA-06-503/CA/NCI NIH HHS/United States
- U01 CA069631/CA/NCI NIH HHS/United States
- U01 CA69398/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous